Skip to content
10-Q

Quarterly Report

Codiak BioSciences, Inc.

0000950170-22-021879

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 27, 2022 36.83M sh
Shares Diluted Q3 2022 · Sep 30, 2022 25.16M sh
Shares Diluted Q3 2022 · Sep 30, 2022 23.37M sh
Shares Diluted Q3 2022 · Sep 30, 2021 22.33M sh
Shares Diluted Q3 2022 · Sep 30, 2021 21.6M sh
Capex Q3 2022 · Sep 30, 2022 $362K
Capex Q3 2022 · Sep 30, 2021 $2.91M
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$45.56M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$52.62M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $51.76M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $76.94M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $98.58M
Stockholders Equity Q3 2022 · Sep 30, 2022 $38.93M
Stockholders Equity Q3 2022 · Jun 30, 2022 $44.4M
Stockholders Equity Q3 2022 · Mar 31, 2022 $48.38M
Stockholders Equity Q3 2022 · Dec 31, 2021 $53.51M
Stockholders Equity Q3 2022 · Sep 30, 2021 $34.01M
Stockholders Equity Q3 2022 · Jun 30, 2021 $51.86M
Stockholders Equity Q3 2022 · Mar 31, 2021 $68.72M
Stockholders Equity Q3 2022 · Dec 31, 2020 $14.57M
Current Liabilities Q3 2022 · Sep 30, 2022 $14.46M
Current Liabilities Q3 2022 · Dec 31, 2021 $27.17M
Total Liabilities Q3 2022 · Sep 30, 2022 $95.47M
Total Liabilities Q3 2022 · Dec 31, 2021 $118.17M
Current Assets Q3 2022 · Sep 30, 2022 $61.23M
Current Assets Q3 2022 · Dec 31, 2021 $90.17M
Total Assets Q3 2022 · Sep 30, 2022 $134.4M
Total Assets Q3 2022 · Dec 31, 2021 $171.67M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.77
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.46
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.97
Eps Diluted Q3 2022 · Sep 30, 2021 −$2.49
Eps Basic Q3 2022 · Sep 30, 2022 −$0.77
Eps Basic Q3 2022 · Sep 30, 2022 −$1.46
Eps Basic Q3 2022 · Sep 30, 2021 −$0.97
Eps Basic Q3 2022 · Sep 30, 2021 −$2.49
Sga Expense Q3 2022 · Sep 30, 2022 $6.56M
Sga Expense Q3 2022 · Sep 30, 2022 $20.63M
Sga Expense Q3 2022 · Sep 30, 2021 $7.19M
Sga Expense Q3 2022 · Sep 30, 2021 $20.71M
Rd Expense Q3 2022 · Sep 30, 2022 $10.85M
Rd Expense Q3 2022 · Sep 30, 2022 $37.89M
Rd Expense Q3 2022 · Sep 30, 2021 $15.47M
Rd Expense Q3 2022 · Sep 30, 2021 $47.44M
Net Income Q3 2022 · Sep 30, 2022 −$19.28M
Net Income Q3 2022 · Sep 30, 2022 −$34.08M
Net Income Q3 2022 · Jun 30, 2022 −$6.78M
Net Income Q3 2022 · Mar 31, 2022 −$8.03M
Net Income Q3 2022 · Sep 30, 2021 −$21.7M
Net Income Q3 2022 · Sep 30, 2021 −$53.82M
Net Income Q3 2022 · Jun 30, 2021 −$21.81M
Net Income Q3 2022 · Mar 31, 2021 −$10.31M
Operating Income Q3 2022 · Sep 30, 2022 −$21.4M
Operating Income Q3 2022 · Sep 30, 2022 −$36.66M
Operating Income Q3 2022 · Sep 30, 2021 −$21.5M
Operating Income Q3 2022 · Sep 30, 2021 −$52.91M
Stock Issued Q3 2022 · Sep 15, 2022 14.03M sh
Stock Issued Q3 2022 · Feb 17, 2021 3.16M sh
Stock Issued Q3 2022 · Oct 16, 2020 5.5M sh